Weekly healthcare intelligenceRegulation · Enforcement · Government payersAll editions →

All articles and reminders · Compliance Sweep

Published November 8, 2026 · Reporting window November 1–7, 2026, Pacific. Later developments are labelled. Source coverage is incomplete; the complete reports describe the limitations.

All articlesSearch this edition →
Compliance Sweep: complete report →

24 articles and reminders, grouped by category.

Compliance Sweep

Higher-priority matters

Payment & health plan rules 3 articles and reminders

Payment & health plan rulesCompliance SweepNew in this edition

CMS proposes CARE rule (CMS-3484-P) to remove hospital and CAH obstetric training and OB QAPI requirements set for January 2027, adopt 2024 Life Safety Code, and drop exterior-window rule

On November 5, 2026, CMS issued the Cutting Administrative Requirements for Excellence in Patient Care (CARE) proposed rule, which would revise Conditions of Participation after a review of the CoPs for all 21 provider and supplier types. For hospitals and critical access hospitals (CAHs) it would remove staff training requirements for emergency services readiness (and, for hospitals, transfer protocols) and for obstetric care, and remove the OB-specific Quality Assessment and Performance Improvement (QAPI) requirements that are otherwise effective January 1, 2027. It would adopt the 2024 National Fire Protection Association (NFPA) Life Safety Code and Health Care Facilities Code. CMS estimates $320 million in savings.

Medium priority · Nov 8, 2026 editionRead story →

Payment & health plan rulesCompliance SweepNew in this edition

OIG adds FAQ: a gift card offered to a Federal health care program beneficiary to induce transfer to an affiliated hospital implicates the anti-kickback statute, and the Beneficiary Inducements CMP for Medicare and State health care program beneficiaries

On November 5, 2026 HHS OIG added a third question to its FAQ page on the application of certain fraud and abuse authorities to certain types of arrangements. The new FAQ addresses whether a hospital may offer a Federal health care program beneficiary or family member a gift card as an incentive to transfer to another hospital in the same health system. For that arrangement, OIG says it would have significant concerns, that the Federal anti-kickback statute would be implicated, that the Beneficiary Inducements Civil Monetary Penalty (CMP) would be implicated if the patient is a Medicare or State health care program beneficiary, and that no safe harbor or exception would apply. OIG defines 'same health system' broadly to cover any affiliated hospital. It lists unfair competition and steering, higher program costs (for example a transfer to a critical access hospital) and quality-of-care risk, and says other forms of transfer remuneration should be evaluated case by case. The FAQ states it does not supersede EMTALA requirements or hospital Conditions of Participation.

Medium priority · Nov 8, 2026 editionRead story →

Payment & health plan rulesCompliance SweepNew in this edition

OIG updated its Health Care Fraud Self-Disclosure Protocol on October 15, 2026, starting the 90-day investigation clock at initial submission

OIG's updated Health Care Fraud Self-Disclosure Protocol (SDP), issued October 15, 2026, makes what OIG calls additional clarifying changes. One change moves the deadline for submitting the completed internal investigation and damages calculation from 90 days after acceptance into the SDP to 90 days after the initial submission; a disclosing party that cannot finish its investigation before sending its submission must certify in that initial submission that it will finish within 90 days of the date of the initial submission. The updated protocol states a general minimum multiplier of 1.5 times single damages and minimum settlements of $100,000 for kickback-related matters and $20,000 for other matters. Earlier editions did not report this update. OIG also listed an updated self-disclosure FAQ on November 2, 2026. The self-disclosure page now carries a question on where to disclose given the new self-disclosure options in 2026, and says conduct that implicates the False Claims Act (FCA), OIG administrative authorities and CMS administrative authorities should be disclosed to the FCA Self-Disclosure Pilot Program. The page does not mark which FAQ text changed on November 2.

Medium priority · Nov 8, 2026 editionRead story →

Governance & business operations 15 articles and reminders

Governance & business operationsCompliance SweepNew in this edition

Eugia recalls one lot of vancomycin injection to the hospital level for glass particulate

Eugia US LLC announced a voluntary nationwide recall of one lot (3VM26026A) of Vancomycin Hydrochloride for Injection USP (United States Pharmacopeia) 1.25g/Vial-30mL to the hospital/healthcare facility/user level because a glass particle was identified inside a vial. The company announcement is dated November 6, 2026; FDA's publish date is November 9, 2026. The company says the entire lot shipped to wholesalers nationwide from September 2 through September 15, 2026, and that it has not received any adverse event reports. Holders of the lot are told to discontinue use and quarantine it immediately.

High priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA early alert: ButterflyBVM bag-valve-mask resuscitators, removal of lots 000109 to 000117 and pre-use test for others

FDA issued an Early Alert on November 3, 2026 about Compact Medical's "Urgent Medical Device Recall" for certain lots of ButterflyBVM single-use bag-valve-mask resuscitators. Lots 000109 through 000117 are to be removed; individually listed earlier lots, numbered between 000081 and 000108 on the FDA page, get a correction: perform the Pre-Use Test before every use and do not use any unit that fails. The reason is a potential hole in the bellows, which FDA says can cause inadequate ventilation and hypoxia. Compact Medical sent letters on September 26 and October 7, 2026, and as of November 2, 2026 had reported no serious injuries or deaths.

High priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

OHCA first-year provisional NOLA (labor-cost adjustment) requests still due November 16, 2026

California's Office of Health Care Affordability (OHCA) enforces health care spending targets set by its Health Care Affordability Board, and the law lets the Board adjust targets when non-supervisory organized labor costs are expected to grow faster than the target, through a Non-Supervisory Organized Labor Adjustment (NOLA). For the first year, OHCA must receive all requests for a provisional NOLA by November 16, 2026 (by the end of October in future years). NOLAs apply to providers and fully integrated delivery systems, not health plans; a labor union may initiate a request but the regulated entity must attest, and all NOLAs are provisional until confirmed with actual expenditure data.

High priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

StatStrip Gen 2.0 glucose meter Class I correction: interim safeguards until the software update

FDA identified Nova Biomedical's correction of its StatStrip Glucose Hospital Meter System as the most serious type of recall (Class I): on the Gen 2.0 model only, prior patient or quality-control information may remain on the meter screen when a barcode is scanned and, if accepted, assign a glucose result to the wrong patient. FDA issued its communication on October 20, 2026 and updated it on October 30 to clarify the recommended actions. Nova intends to roll out a software update in November 2026 in a phased manner; until then users follow updated instructions or, if an alternative meter is available, stop using the affected meter.

High priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

Medline-brand beds and accessories early alert: fire and entrapment risks, use under updated instructions until repair or replacement

FDA issued an Early Alert, listed October 29, 2026, on a potentially high-risk device issue: Medline told customers on October 14, 2026 that it is removing, discontinuing and exiting the market for all Medline Brand beds and associated components, including homecare, bariatric and long-term care beds, pendants, accessories, replacement parts and bed-containing order packages. Medline identified a potential fire hazard involving the beds, hand-control pendants, control/motor boxes and actuators/motors, and a separate risk of entrapment or asphyxiation when the beds are used with any bed accessories, when a user lies on a pendant being used with the bed, or when the bed is used with loose or wobbly rails, and as of October 20, 2026 had reported two deaths and 16 serious injuries associated with these issues. Under Medline's October 24, 2026 update, covered beds, rails, mattresses and accessories may remain in use under updated instructions until the bed is repaired or replaced.

High priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

B. Braun Dialog+ bloodline early alert: three Streamline Bloodline Set lots removed over connector detachment risk

FDA issued an Early Alert on a potentially high-risk device issue: B. Braun Medical Inc. has recommended to customers that lots A2600099, A2600128 and A2600136 of its Streamline Bloodline Set for Dialog+, model SL-2010M2096, be removed from where they are used or sold. B. Braun stated that a required solvent application step during assembly was not performed, leaving the dialyzer connector inadequately bonded, so the bloodline connector may detach or leak during priming or dialysis treatment, potentially leading to blood loss, clotting and occlusion of the extracorporeal circuit, or air entering the blood circuit. B. Braun sent customers a letter on October 20, 2026, and the earlier article reported FDA's device-safety listing of the alert on October 27, 2026.

High priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

HemosIL AcuStar HIT-IgG(PF4-H) lot recall: destroy listed lots and document on the response form

FDA identified as the most serious type of recall the removal of four lots of an assay that, with other laboratory and clinical findings, aids in determining the risk for heparin-induced thrombocytopenia (HIT): HemosIL AcuStar HIT-IgG(PF4-H), from Instrumentation Laboratories (Werfen). Werfen found a performance issue in lots B40005, B40006, B38062 and B38063 that may cause a negative bias, so sample results could be incorrectly reported below the assay cut-off (1.00 U/mL) and be interpreted as HIT IgG antibody negative. The earlier article reported FDA's listing of the confirmed recall on October 30, 2026, and FDA says a supply interruption is expected.

High priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

Transparency in Coverage final rule: phased machine-readable file and phone-disclosure duties still ahead

The Transparency in Coverage final rule (FR Doc. 2026-20447, 91 FR 63748), published in the Federal Register on October 6, 2026 and effective December 7, 2026, sets new disclosure duties for non-grandfathered group health plans and health insurance issuers: in-network rate files for each provider network, out-of-network allowed-amount files for each health insurance market, new contextual files, a website footer link labeled Price Transparency or Transparency in Coverage, attestations in the files, and cost-sharing information available by phone. The duties phase in for plan years (policy years in the individual market) beginning on or after January 1, 2027 (the amended cost-sharing disclosures, including the phone method), on March 6, 2027 (the rate and allowed-amount file changes and attestations) and on September 6, 2027 (the contextual files and footer), with the first utilization file due July 1, 2028; until each date the prior rules continue to apply.

High priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

CDPH AFL 26-33 updates hospital respiratory-virus surge guidance for 2026-2027 and supersedes AFL 23-30

CDPH issued All Facilities Letter (AFL) 26-33 on November 4, 2026 to general acute care hospitals and acute psychiatric hospitals, superseding AFL 23-30. The letter gives planning and response guidance for an anticipated adult and pediatric surge in respiratory illness and updates surge measures and clinical resources for the 2026-2027 season. It says facilities that anticipate needing flexibility to prepare for surges should submit a program flexibility request through the Risk and Safety Solutions (RSS) website and obtain approval for any alternative use of space or bed classification. It restates that, where already applicable, facilities must continue to adhere to the Aerosol Transmissible Diseases (ATD) standard of Cal/OSHA (the California Division of Occupational Safety and Health), and it asks hospitals to prepare for a surge of at least 20 percent over licensed capacity.

Medium priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

Labor Department finalizes PBM fee-disclosure rule for large self-insured ERISA health plans

The Labor Department's Employee Benefits Security Administration (EBSA) published a final rule (Regulation Identifier Number (RIN) 1210-AB37, 29 CFR part 2550) requiring providers of pharmacy benefit management services, and affiliated brokerage and consulting providers, to disclose compensation to fiduciaries of large self-insured Employee Retirement Income Security Act (ERISA) group health plans as a condition of the ERISA section 408(b)(2) prohibited transaction exemption. The rule is effective January 4, 2027, and applies to plan years beginning on or after July 1, 2027. Initial disclosures are due in writing reasonably in advance of the date the contract or arrangement is entered into, extended or renewed; for an extension or renewal, the rule text deems 90 calendar days in advance a reasonable period, and the preamble describes that as applying absent an agreement between the provider and the plan to a longer timeframe, followed by semiannual disclosures or quarterly at the plan's request. Under the administrative exemption, if a service provider does not comply with a written request within 90 calendar days, the responsible plan fiduciary must decide whether to terminate or continue the arrangement and document the basis.

Medium priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA classifies Abiomed Automated Impella Controller removal as Class I

FDA's weekly Enforcement Report dated November 4, 2026 lists three Class I recall entries (Z-0208-2027, Z-0209-2027, Z-0210-2027) for Abiomed Automated Impella Controller (AIC) products, classified October 28, 2026. Abiomed's review of servicing records found controllers needing hardware, firmware or software updates, with issues including failure to recognize the purge cassette, a sticking button and possible loss of console control, and start-up instability. FDA's recall page, updated after this edition's coverage week, says hospital inventory can continue to be used while awaiting service from Abiomed.

Medium priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

Cardinal Health Presource kits with recalled BD Alaris infusion sets: correction posted in FDA recall database

FDA's medical device recall database posted on November 2, 2026 a Cardinal Health correction (record Z-0217-2027) for Presource kits containing BD Alaris pump infusion sets that were themselves recalled for performance issues; the record lists 415,636 kits. Cardinal's September 24, 2026 notice asked consignees to discontinue use of the affected BD Alaris pump infusion sets as the enclosed Becton Dickinson notice describes and, where affected kits are found, to quarantine them, alert clinicians, and affix a warning label to each kit telling clinicians to remove and discard the recalled components. Those instructions belong to record Z-0217-2027. A separate FDA recall page for Presource kits, updated November 9, 2026 (after this edition's coverage week), says the FDA has identified the recall it describes as the most serious type. The FDA records reviewed for this entry do not show that page and database record Z-0217-2027 to be the same recall event, so the classification of Z-0217-2027 is not established here.

Medium priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

Baxter TruSystem surgical tables: correction for unexpected lift drop posted in FDA recall database

FDA's recall database posted on November 3, 2026 a set of Baxter correction entries (including Z-0350-2027) for TruSystem surgical tables and columns. Baxter reports the main lift may unexpectedly drop to its lowest position during use and the tabletop may not rise again, which could cause abrupt patient displacement during surgery; Baxter has three complaints and no reported patient injury. Baxter's September 29, 2026 letter tells customers to keep monitoring the table, stop using it if an unusual noise occurs, and post the notice by the devices until the correction is done.

Medium priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

Off-campus provider-based departments need a separate NPI and a provider-based attestation (by December 31, 2027 for departments furnishing services on or before January 1, 2028), or lose OPPS payment from January 1, 2028

CMS codified section 6225 of the Consolidated Appropriations Act, 2026 at new 42 CFR 419.23 and 413.65(b)(6). No Outpatient Prospective Payment System (OPPS) payment may be made for items and services furnished on or after January 1, 2028, by an off-campus outpatient department unless the department has its own NPI separate from the main provider and the main provider has submitted an initial provider-based attestation. For departments furnishing services on or before January 1, 2028, initial attestations must be submitted between January 1, 2026 and December 31, 2027; a department is all hospital operations at one physical address listed in the Provider Enrollment, Chain, and Ownership System (PECOS). Before attesting, the main provider must obtain an NPI for each department and update PECOS. Departments that received an affirmative provider-based determination before January 1, 2026 must submit a new attestation. A timely attestation counts even if CMS has not issued a determination by the first date of service. CMS will use a standardized form and a centralized electronic system, will not require supporting documentation with the initial attestation, and will use risk-based review, remote audits and site visits; until the new system is final, attestations may go to the Medicare Administrative Contractor (MAC) under existing 413.65(b)(3)(ii).

Medium priority · Nov 8, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

CDPH notices readoption of acute psychiatric hospital nurse-to-patient ratio emergency regulations; 5-day period ran November 2 to 6

CDPH issued All Facilities Letter (AFL) 26-32 on October 30, 2026, giving acute psychiatric hospitals a 5-day notice that it proposes to readopt, on an emergency basis, Title 22 sections 71213.1 and 71215.1, which set nurse-to-patient ratio standards under Health and Safety Code section 1276.4. The 5-working-day period ran from November 2 to November 6, 2026, during this edition's coverage week. CDPH stated it will submit the readoption to the Office of Administrative Law (OAL) on November 9, 2026, to be in effect November 28, 2026, and that OAL allows five calendar days for comments after submission.

Medium priority · Nov 8, 2026 editionRead story →

More matters and continuing watch

Privacy & health information 1 articles and reminders

AI & digital health 1 articles and reminders

Governance & business operations 4 articles and reminders

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies